Specific infectious complications after stem cell transplantation
- 1 February 2004
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 12 (2) , 80-85
- https://doi.org/10.1007/s00520-003-0511-3
Abstract
Infectious complications continue to be a leading cause of morbidity and mortality after stem cell transplantation (SCT). The most important determinants for risk and outcomes are the stem cell source and the time after transplantation that the infection occurs. More recent developments in preparative regimens and graft manipulations, as well as the control of some important infectious complications after SCT by the introduction of effective prophylaxis and preemptive treatment strategies, have had a great impact on the timing and the epidemiology of infections posttransplantation. Better control of infectious complications posttransplantation has resulted in a reduced transplant-related mortality.Keywords
This publication has 33 references indexed in Scilit:
- Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood productsBlood, 2003
- Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignanciesBlood, 2002
- AspergillusGalactomannan Detection in the Diagnosis of Invasive Aspergillosis in Cancer PatientsJournal of Clinical Oncology, 2002
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- Evaluation of Use of Epstein-Barr Viral Load in Patients after Allogeneic Stem Cell Transplantation To Diagnose and Monitor Posttransplant Lymphoproliferative DiseaseJournal of Clinical Microbiology, 2002
- Risk for cytomegalovirus disease in patients receiving polymerase chain reaction–based preemptive antiviral therapy after allogeneic stem cell transplantation depends on transplantation modalityBlood, 2001
- Early Detection ofAspergillusInfection after Allogeneic Stem Cell Transplantation by Polymerase Chain Reaction ScreeningThe Journal of Infectious Diseases, 2000
- Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cellsBlood, 2000
- Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 1999
- Infection in the bone marrow transplant recipient.1995